Fischer Medical Ventures Approves Q1 FY27 Results, Directors Resign
Fischer Medical Ventures Ltd announced the approval of its unaudited financial results for Q1 FY2026-27. The company reported a standalone loss before tax of ₹322.99 lakhs for the quarter ended June 30, 2026, compared to a loss of ₹21.56 lakhs in the same period last year. Total income for the quarter stood at ₹534.63 lakhs. The Board also noted the resignation of two Independent Directors, Mr. Roberto M Pagdanganan and Mr. Sanjay Jayantilal Jain, effective August 14, 2026. Consequently, the Audit Committee and Nomination and Remuneration Committee have been reconstituted. Additionally, the company approved the allotment of 2,05,05,909 equity shares pursuant to the conversion of warrants.
Key Highlights
- Q1 FY27 standalone loss before tax ₹322.99 lakhs.
- Total income for Q1 FY27 was ₹534.63 lakhs.
- Two Independent Directors resigned from the Board.
- Audit and Remuneration Committees were reconstituted.
- 2.05 crore equity shares allotted via warrant conversion.
Price Impact
More from FISCHER
More in Quarterly Result